BridgeMD
New treatment option for Atrial Fibrillation (AF)
Official title The Effect of a Digital MediYoga Program on Quality of Life, Blood Pressure and Heart Rate Among Patients With Atrial Fibrillation
ClinicalTrials.gov ID: NCT07321964
What this study is testing
- What it's testing
- Atrial fibrillation (AF) is the most common cardiac arrythmia, associated with increased risk of stroke, heart failure, reduced quality of life (QoL), and psychological distress. This randomized controlled trial investigates the effect of MediYoga - a program incorporating deep breathing, low-intensity yoga, and meditation- on disease-specific QoL, blood pressure, and heart rate in 456 patients with paroxysmal AF.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Aged 18 and above
- Diagnosed with paroxysmal atrial fibrillation
- EHRA score at 2 or more
- Owner of a smartphone or tablet
- Speaking and reading Danish
You likely can't join if
- Elevated TSH Hormone
- Participated in mindfulness or yoga exercise regularly at any point during the last two years.
See the full eligibility criteria
- Aged 18 and above
- Diagnosed with paroxysmal atrial fibrillation
- EHRA score at 2 or more
- Owner of a smartphone or tablet
- Speaking and reading Danish
- No comorbidity that restricts them from participating in the intervention
- Elevated TSH Hormone
- Participated in mindfulness or yoga exercise regularly at any point during the last two years.
The study team makes the final eligibility decision.
Where it's taking place
- Herlev, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Herlev, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.